IONS FY 2020 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$729M-35.0% YoY

Gross Profit

$717M98.4% margin

Operating Income

-$172M-23.6% margin

Net Income

-$444M-60.9% margin

EPS (Diluted)

$-3.18

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

-$5M

Stock-Based Comp.

$230M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.6B

Stockholders' Equity

$743M

Cash & Equivalents

$398M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$729M	$1.1B	-35.0%
Gross Profit	$717M	$1.1B	-35.9%
Operating Income	-$172M	$366M	-147.0%
Net Income	-$444M	$278M	-259.7%